Comparison of {sup 18}F-Fluorothymidine and {sup 18}F-Fluorodeoxyglucose PET/CT in Delineating Gross Tumor Volume by Optimal Threshold in Patients With Squamous Cell Carcinoma of Thoracic Esophagus
Journal Article
·
· International Journal of Radiation Oncology, Biology and Physics
OSTI ID:21372185
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Jinan, Shandong Province (China)
- Department of Nuclear Medicine, Shandong Cancer Hospital and Institute, Jinan, Shandong Province (China)
- Department of Pathology, Shandong Cancer Hospital and Institute, Jinan, Shandong Province (China)
- Department of Thoracic Surgery, Shandong Cancer Hospital and Institute, Jinan, Shandong Province (China)
Purpose: To determine the optimal method of using {sup 18}F-fluorothymidine (FLT) positron emission tomography (PET)/computed tomography (CT) simulation to delineate the gross tumor volume (GTV) in esophageal squamous cell carcinoma verified by pathologic examination and compare the results with those using {sup 18}F-fluorodeoxyglucose (FDG) PET/CT. Methods and Materials: A total of 22 patients were enrolled and underwent both FLT and FDG PET/CT. The GTVs with biologic information were delineated using seven different methods in FLT PET/CT and three different methods in FDG PET/CT. The results were compared with the pathologic gross tumor length, and the optimal threshold was obtained. Next, we compared the simulation plans using the optimal threshold of FLT and FDG PET/CT. The radiation dose was prescribed as 60 Gy in 30 fractions with a precise radiotherapy technique. Results: The mean +- standard deviation pathologic gross tumor length was 4.94 +- 2.21 cm. On FLT PET/CT, the length of the standardized uptake value 1.4 was 4.91 +- 2.43 cm. On FDG PET/CT, the length of the standardized uptake value 2.5 was 5.10 +- 2.18 cm, both of which seemed more approximate to the pathologic gross tumor length. The differences in the bilateral lung volume receiving >=20 Gy, heart volume receiving >=40 Gy, and the maximal dose received by spinal cord between FLT and FDG were not significant. However, the values for mean lung dose, bilateral lung volume receiving >=5, >=10, >=30, >=40, and >=50 Gy, mean heart dose, and heart volume receiving >=30 Gy using FLT PET/CT-based planning were significant lower than those using FDG PET/CT. Conclusion: A standardized uptake value cutoff of 1.4 on FLT PET/CT and one of 2.5 on FDG PET/CT provided the closest estimation of GTV length. Finally, FLT PET/CT-based treatment planning provided potential benefits to the lungs and heart.
- OSTI ID:
- 21372185
- Journal Information:
- International Journal of Radiation Oncology, Biology and Physics, Journal Name: International Journal of Radiation Oncology, Biology and Physics Journal Issue: 4 Vol. 76; ISSN IOBPD3; ISSN 0360-3016
- Country of Publication:
- United States
- Language:
- English
Similar Records
Impact of computed tomography and {sup 18}F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer
Comparison of Five Segmentation Tools for {sup 18}F-Fluoro-Deoxy-Glucose-Positron Emission Tomography-Based Target Volume Definition in Head and Neck Cancer
SU-E-T-500: Dose Escalation Strategy for Lung Cancer Patients Using a Biologically- Guided Target Definition
Journal Article
·
Wed Nov 30 23:00:00 EST 2005
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:20788236
Comparison of Five Segmentation Tools for {sup 18}F-Fluoro-Deoxy-Glucose-Positron Emission Tomography-Based Target Volume Definition in Head and Neck Cancer
Journal Article
·
Wed Nov 14 23:00:00 EST 2007
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:21039646
SU-E-T-500: Dose Escalation Strategy for Lung Cancer Patients Using a Biologically- Guided Target Definition
Journal Article
·
Sun Jun 01 00:00:00 EDT 2014
· Medical Physics
·
OSTI ID:22369741
Related Subjects
62 RADIOLOGY AND NUCLEAR MEDICINE
ANTIMETABOLITES
BETA DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
BODY
CARCINOMAS
CARDIOVASCULAR SYSTEM
CHEST
COMPUTERIZED TOMOGRAPHY
DIAGNOSTIC TECHNIQUES
DIGESTIVE SYSTEM
DISEASES
DRUGS
EMISSION COMPUTED TOMOGRAPHY
ESOPHAGUS
FLUORINE 18
FLUORINE ISOTOPES
FLUORODEOXYGLUCOSE
FRACTIONATED IRRADIATION
HEART
HOURS LIVING RADIOISOTOPES
IRRADIATION
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LIGHT NUCLEI
LUNGS
MEDICINE
NANOSECONDS LIVING RADIOISOTOPES
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-ODD NUCLEI
ORGANS
POSITRON COMPUTED TOMOGRAPHY
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
RESPIRATORY SYSTEM
SIMULATION
THERAPY
TOMOGRAPHY
ANTIMETABOLITES
BETA DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
BODY
CARCINOMAS
CARDIOVASCULAR SYSTEM
CHEST
COMPUTERIZED TOMOGRAPHY
DIAGNOSTIC TECHNIQUES
DIGESTIVE SYSTEM
DISEASES
DRUGS
EMISSION COMPUTED TOMOGRAPHY
ESOPHAGUS
FLUORINE 18
FLUORINE ISOTOPES
FLUORODEOXYGLUCOSE
FRACTIONATED IRRADIATION
HEART
HOURS LIVING RADIOISOTOPES
IRRADIATION
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LIGHT NUCLEI
LUNGS
MEDICINE
NANOSECONDS LIVING RADIOISOTOPES
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-ODD NUCLEI
ORGANS
POSITRON COMPUTED TOMOGRAPHY
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
RESPIRATORY SYSTEM
SIMULATION
THERAPY
TOMOGRAPHY